- Mar. 10, 2014 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that William G. Dempsey has been elected to its Board of Directors. He currently serves as a director of Landauer, Inc., Nordion Inc., and Hospira, Inc., and previously held various executive positions with Abbott Laboratories, including Executive Vice President of Global Pharmaceuticals, Senior Vice President of Pharmaceutical Operations, and Senior Vice President of International Operations. He also previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.
- Mar. 7, 2014 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors has increased the company's fiscal year 2014 second quarter dividend 11 percent to $0.1525 per share. This dividend is payable on March 31, 2014 to shareholders of record as of the close of business on March 20, 2014. This brings the annualized dividend rate per share to $0.61 from $0.55.
- BATESVILLE, Ind., Feb. 25, 2014 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) has announced major partnerships with GOJO, makers of Purell® hand sanitizer, and TeleTracking Technologies, a world leader in real-time health care patient flow systems, to co-market integrations with the Hill-Rom® Hand Hygiene Compliance Solution. The partnerships debuted this week at HIMSS, the industry’s largest health information technology meeting, in Orlando, Fla.